Biolytica has developed a health data platform it calls NEXUS. The artificial-intelligence-driven (AI-driven) platform analyses and aggregates data from genomics, blood, microbiome, and epigenetic biomarkers, wearable devices, and lifestyle data. It is designed to help clinicians create unique and hyper-personalised plans for their clients and monitor their progress. 

For individuals, the company also offers AIME, a personalised longevity program based on detailed analysis of genetic information and lifestyle factors. Users have access to Biolytica’s team of longevity experts and receive personalised recommendations and an actionable plan to slow, stop, or postpone ageing processes.

Article written by Springwise




Enviar comentario

Conectado como Marcos Gullén. Edita tu perfil. ¿Salir? Los campos obligatorios están marcados con *